Johnson Controls
JCI
$114.23 0.03%
Exchange: NYSE | Sector: Industrials | Industry: Construction
Q3 2024
Published: Jul 31, 2024

Earnings Highlights

  • Revenue of $7.23B up 1.4% year-over-year
  • EPS of $1.45 decreased by 5.8% from previous year
  • Gross margin of 34.3%
  • Net income of 975.00M
  • ""Two divestitures... represent roughly 20% of current sales. These two transactions represent roughly 20% of current sales."" - George Oliver
JCI
Company JCI

Executive Summary

Johnson Controls (JCI) delivered a solid fiscal third quarter 2024, underscoring the ongoing benefits of its portfolio transformation and the growing contribution from higher-margin, recurring revenue. Organic revenue rose 3% in the quarter, led by resilient service growth and a favorable mix shift from higher-margin backlog, with total revenue of approximately $7.2 billion. Segment margins expanded 150 basis points to 17.9%, supported by productivity gains and the monetization of higher-margin backlog. Adjusted earnings per share (EPS) reached $1.14, up 11% year over year and topping the high end of guidance by $0.04, while GAAP net income was $975 million. Free cash flow was robust, with year-to-date free cash flow up about $700 million to roughly $1.3 billion, and net debt at approximately 2.3x within the company’s long-term target window of 2.0x–2.5x. Management reiterated progress on the portfolio transformation, including two major divestitures that shift the company toward a pure-play provider of engineered solutions for commercial buildings. The planned divestitures—Residential and Light Commercial HVAC to Bosch for about $8.1 billion (net ~$5 billion after tax) and Air Distribution Technologies to Truelink—represent roughly 20% of current sales and are expected to close in about 12 months with discontinued operations reported beginning in Q4 2024. In a parallel thread, CEO George Oliver signaled continued momentum in the data center vertical, with backlog approaching double-digit growth and a positive, multi-year outlook. The quarter also featured leadership and governance actions, including the initiation of a CEO succession process and the appointment of Patrick Decker to the Board. For the full year, JCI tightened guidance to adjusted EPS of $3.66–$3.69, with organic sales around 3% and free cash flow conversion anticipated at ~85% or better. Translation for investors: the company is transitioning to a higher-growth, higher-margin business with stronger recurring revenue, while actively simplifying the portfolio and maintaining a disciplined capital allocation framework.

Key Performance Indicators

Revenue
Increasing
7.23B
QoQ: 7.94% | YoY: 1.37%
Gross Profit
Increasing
2.48B
34.30% margin
QoQ: 13.71% | YoY: 2.02%
Operating Income
Increasing
1.39B
QoQ: 2 088.57% | YoY: 115.81%
Net Income
Decreasing
975.00M
QoQ: 451.99% | YoY: -7.05%
EPS
Decreasing
1.45
QoQ: 453.66% | YoY: -5.84%

Revenue Trend

Margin Analysis

Historical Earnings Comparison

PeriodRevenue ($M)EPS ($)YoY GrowthReport
Q2 2025 5,676.00 0.72 -15.3% View
Q1 2025 5,426.00 0.55 -11.0% View
Q4 2024 2,928.00 0.95 -57.6% View
Q3 2024 7,231.00 1.45 +1.4% View
Q2 2024 6,699.00 -0.41 +0.2% View